Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

First transmission of NDM bacteria between dog and human
This study is presumed to be the first in which researchers have shown the transmission of NDM-bacteria between dogs and humans.
Researchers isolate highly resistant strain from family dogs and owner

Researchers in Finland have reported the first-ever transmission of New Delhi metallo-beta-lactamase (NDM) bacteria between a dog and a human.

In 2015, NDM bacteria were identified in two Finnish dogs. Now, writing in the journal Eurosurveillance, Dr Thomas Grönthal and his team reveal that the owner of the dogs also carried the bacteria.

Dr Grönthal explains: “We were able, through the analysis of the genome of the bacteria, to conclude that the bacterial isolates from the dogs and humans were identical, which means that they were transmitted between dogs and humans.”

The study was a collaboration between the University of Helskini, the National Institute of Health and Welfare, and the Finish Food Safety Authority.

Researchers isolated a highly resistant NDM-5 producing bacterial strain from two family dogs and one of the family members. Both dogs and two members of the family also carried a multidrug-resistant ESBL bacterium.

The ESBL and the NDM bacterial strains researchers isolated from the humans and dogs were identical. However, the humans did not show any symptoms and the researchers were unable to identify the source of the NDM bacteria.

“We could not show with certainty in which direction the bacteria had transmitted, explains lead researcher Merja Rantala. “However, especially the NDM-bacteria probably moved from human to dog as these bacteria have not previously been identified in animals in Finland.”

“The use of carbapenem antibiotics in animals is prohibited in Finland, but the dogs had received numerous other antibiotics. This gave the NDM-bacteria a competitive edge and enabled them to persist in the dogs.”

This study is presumed to be the first in which researchers have shown the transmission of NDM-bacteria between dogs and humans. However, car­bapenemase-pro­du­cing bac­teria are becoming more common in animals.

Researchers recommend that laboratories investigating animal specimens should monitor the susceptibility of bacteria to carbapenems and extended-spectrum cephalosporins.

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.